OpenBilldrug price receipt

NADAC week of 2026-10-14

HUMULIN 70/30 KWIKPEN

FDA nonproprietary name: insulin human

For 15 mL

Pharmacies pay

$135.52 filed

15 × $9.0349 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$160.85 estimated

$135.52 + $20.33 (15%) + $5.00 fee per fill = $160.85

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

HUMULIN 70/30 KWIKPEN is how the CMS NADAC file names this product. The FDA NDC Directory lists it as insulin human, under the trade name “Humulin 70/30 KwikPen”.

FDA gives its dosage form as injection, suspension and its route as subcutaneous.

The labeler, the company named on the label, is Eli Lilly and Company.

FDA’s Established Pharmacologic Class for it is Insulin.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00002-8803-59.

NADAC classes it as a brand-name drug (rate-setting class B), and marks it as sold over the counter.

What pharmacies pay

Pharmacies pay $135.52 for 15 mL (15 × $9.0349 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

The NDC

Other strengths, forms and brands

11 other products in the NADAC file share the FDA nonproprietary name insulin human with HUMULIN 70/30 KWIKPEN.

ProductPharmacies pay per unitMedicare per unit
AFREZZA ((REGULAR INSULIN) 8 UNIT CARTRIDGE
brand · powder, metered
$10.3754 per EA filed
eff. 2026-09-23
$8.98197 per EA filed
Part D 2024 average
AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE
brand · powder, metered
$5.20552 per EA filed
eff. 2026-09-23
$8.98197 per EA filed
Part D 2024 average
AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE
brand · powder, metered
$15.65297 per EA filed
eff. 2026-05-20
$8.98197 per EA filed
Part D 2024 average
AFREZZA (REGULAR INSULIN) 60-4 UNIT/60-8 UNIT/60-12 UNIT
brand · kit
$10.33288 per EA filed
eff. 2026-09-23
$8.98197 per EA filed
Part D 2024 average
AFREZZA (REGULAR INSULIN) 90-4 UNIT / 90-8 UNIT
brand · kit
$7.78053 per EA filed
eff. 2026-09-23
$8.98197 per EA filed
Part D 2024 average
AFREZZA (REGULAR INSULIN) 90-8 UNIT / 90-12 UNIT
brand · kit
$13.03769 per EA filed
eff. 2026-04-01
$8.98197 per EA filed
Part D 2024 average
HUMULIN 70-30 VIAL
brand · injection, suspension
$4.25636 per ML filed
eff. 2026-09-23
We don’t know yet
HUMULIN 70/30 KWIKPEN this page
brand · injection, suspension
$9.0349 per ML filed
eff. 2026-09-23
We don’t know yet
HUMULIN N 100 UNIT/ML KWIKPEN
brand · injection, suspension
$9.03325 per ML filed
eff. 2026-09-23
$6.74415 per ML filed
Part D 2024 average
HUMULIN N 100 UNIT/ML VIAL
brand · injection, suspension
$4.26742 per ML filed
eff. 2026-09-23
$3.79166 per ML filed
Part D 2024 average
HUMULIN R 100 UNIT/ML VIAL
brand · injection, solution
$4.2629 per ML filed
eff. 2026-09-23
$4.00953 per ML filed
Part D 2024 average
HUMULIN R 500 UNIT/ML KWIKPEN
brand · injection, solution
$91.60736 per ML filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-01, 2026-05-20, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $9.0349 per ML filed.

Of the 11 other products in FDA’s Insulin class priced per ML, 1 has a higher middle NADAC price and 10 a lower one. The one in the middle is NOVOLIN 70-30 100 UNIT/ML VIAL, at $4.62659 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 15 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 15 mL in one package for this product’s NDC (“5 SYRINGE in 1 CARTON (0002-8803-59) / 3 mL in 1 SYRINGE (0002-8803-01)”), so the card starts at one package: 15 ML. Change it to match your prescription.